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Abstract
An aqueous extract of Rhizophora mangle L. bark is used as raw material in pottery making in the State of Espirito
Santo, Brazil. This extract presents large quantities of tannins, compounds possessing antioxidant properties. Tan-
nin antioxidant activity, as a plant chemical defense mechanism in the process of stabilizing free radicals, has been
an incentive to studies on anti-mutagenicity. The present work aimed to evaluate possible antimutagenic activity of a
R. mangle aqueous extract, using the Allium cepa test-system and micronuclear (MN) assay with blockage of
cytokinesis in Chinese hamster ovary cells (CHO-K1). The Allium cepa test-system indicated antimutagenic activity
against the damage induced by the mutagenic agent methyl methanesulfonate. A reduction in both MN cell fre-
quency and chromosome breaks occurred in both the pre and post-treatment protocols. The MN testing of CHO-K1
cells revealed anti-mutagenic activity of the R. mangle extract against methyl methanesulfonate and doxorubicin in
pre, simultaneous and post-treatment protocols. These results suggest the presence of phyto-constituents in the ex-
tract presenting demutagenic and bio-antimutagenic activities. Since the chemical constitution of Rhizophora man-
gle species presents elevated tannin content, it is highly probable that these compounds are the antimutagenic
promoters themselves.
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Rhizophora mangle L. (Rhizophoraceae) is a native
mangrove species, with large quantities of tannins, mainly
concentrated in the bark. According to Sanchez et al.
(1998), the chemical constitution of an aqueous extract of
R. mangle bark presents 54% in tannin content. On manu-
facturing the traditional clay cooking pots of Espírito San-
to, and as part of the process followed by the Goiabeiras
pot-makers association of Vitória, ES, Brazil, a R. mangle
L.extractisusedtocurethepots,therebybestowingimper-
meability. In traditional medicine, the extract is also used
for treating wounds, bacteriological inflammation and fun-
gal diseases (Roig, 1974).
Ethnopharmacological reports are considered part of
pre-triage strategy when searching for bioactive com-
pounds in plants, since it is more likely that such com-
poundswillbeidentifiedinplantsalreadyinuseintraditio-
nal medicine than in randomly selected plants (Houghton
and Raman, 1998). However, the realization of biological
assays, in vitro and in vivo, is required to scientifically vali-
date plants indicated by popular use.
In vitro tests are valuable in the study of medicinal
plants, due to their greater reproducibility, shorter experi-
mental periods and because they require smaller quantities
of the target compounds. However, certain pharmacologi-
cal actions also require the realization of in vivo tests, since
these assays permit the analysis of other factors that influ-
ence the action of the active principal, such as administra-
tionroute,absorption,metabolizationandexcretion(Calix-
to, 2001).
The mutagenic and antimutagenic potential of phyto-
constituents present in plant and fungus extracts have been
widely evaluated by means of in vivo assays involving
Allium cepa and in vitro assays using Chinese hamster
ovary (CHO-K1) cells.
Short duration tests involving the CHO-K1 system
are indicated, due to the advantages offere, because the fa-
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Short Communicationcility in standardizing experimental conditions (tempera-
ture, pH, culture medium composition and population
density), the, metabolic and behavioral uniformity of the
material, the possibility of undertaking cell treatment in
several cell cycle phases, quickness, economy, adequate
reproducibility, and chromosome and DNA organization
equivalent to in vivo cells (Rodrigues and Monteleone-
Neto, 1991). Assays using the genus Allium have been car-
ried out since 1930, although their modus operandi was
only standardized in 1985 by Fiskejö. The most frequently
usedspeciesisAlliumcepa,sincethedurationofitscellcy-
cle is well-known, root growth is fast, cell division occurs
in a large number of cells, it displays high tolerance to di-
verse culture conditions, it reacts to many known muta-
genic agents, and its possesses only a few small-sized
chromosomes (Evseeva and Khramova, 2002; Fiskejö,
1985; Matsumoto and Marin-Morales, 2004; Matsumoto et
al., 2006). The aim was to evaluate the cytotoxic and
antimutagenic potential of an aqueous extract of
RhizophoramangleL.bark,usedinthemakingofclaypots
andintraditionalmedicine,byAlliumcepaandcelltesting,
besides Chinese hamster ovary (CHO-K1) cell culture.
TopreparetheaqueousextractofRhizophoramangle
L. bark, 300 g of plant bark were added to 900 mL of
ultrapure water, where the bark remained immersed for
72 h. After this period, the solution was filtered, producing
a crude extract of R. mangle bark at a concentration of
28 g/L. The extract obtained was submitted to pharma-
cognostic triage (Farmacopéia Brasileira, 2001). Tests
were performed to identify flavanoids, terpenes, naphtho-
quinones, coumarin, saponins, anthracene heterosides, tan-
nins and alkaloids. Determination of tannin dosage was
performed using methods described in the Farmacopéia
Brasileira (2001), with certain adaptation. To prepare the
mother solution, 0.75 g of lyophilized Rhizophora mangle
extractwasdissolvedin150mLofultrapurewater.Theso-
lution was then boiled, and maintained in a water bath at
80-90 °C for 30 min. After cooling and decantation, the
sediment was filtered out. Total polyphenols (A1): 5 mL of
the mother solution was transferred to a 25 mL volumetric
balloon, whereupon the volume was completed with ultra-
pure water. In a 50 mL balloon,a5m Laliquot of this pre-
pared solution was added to 2 mL of phosphotungstic acid.
The balloon volume was completed with a sodium carbon-
ate solution. Polyphenols not absorbed on skin powder
(A2): 0.2 g of skin powder were added to 20 mL of the
mother solution and stirred for 60 min. The resulting solu-
tion was filtered, and 5 mL diluted to 25 mL by adding
ultrapurewater.Ina50mLvolumetricballoon,5mLofthe
prepared solution was added to 2 mL of phosphotungstic
acid. The balloon volume was completed with a sodium
carbonate solution. Absorbance of solutions A1 and A2
was measured at 691 nm, 3 min after adding the last re-
agent, and using water as white-standard. The reference so-
lution (A3) consisted of 50 mg of pyrogallol dissolved in
100 mL ultrapure water. In a 100 mL volumetric balloon,
5 mL of this solution were diluted to 100 mL using ultra-
pure water. In a 50 mL volumetric balloon, 5 mL of the lat-
terwasaddedto2mLofphosphotungsticacid.Theballoon
volume was completed with a sodium carbonate solution.
The absorbance of solution A3 was measured at 691 nm,
3 min after the addition of the final reagent and within
15 min of dissolving the pyrogallol, with water as white
standard.Thetannincontentwascalculatedbytheequation
TT 13.12
A1 A2
A3 m



where TT = total tannins, A1 = mean absorbance of total
polyphenols,A2=meanabsorbanceofpolyphenolsnotab-
sorbed on skin powder, A3 = mean absorbance of the refer-
ence compound and m = mass of the lyophilized extract,
in g.
The assay was done in triplicate and statistical analy-
sis was performed by ANOVA (p < 0.05).
To determine the dilution of the extract for use in the
antimutagenicity assays, preliminary toxicity tests were re-
alized on A. cepa seeds, using various concentrations
(28.0 g/L, 14.0 g/L, 7.0 g/L, 3.5 g/L and 1.75 g/L), to deter-
mine the concentration that would best respond to the
antimutagenicity assays.
For each extract concentration tested, 25 seeds were
left to germinate until root-length reached approximately
1 cm. Negative control was carried out with ultrapure wa-
ter. Macroscopic parameters (root size and morphology)
and the mitotic index were taken into consideration for
evaluation of extract-toxicity. The roots were fixed and
stained for cytological analysis by the Feulgen method
(Mello and Vidal, 1978).
Toevaluatetheanti-mutagenicpotentialofR.mangle
aqueous extract, DNA molecular damage was induced in
meristematic cells of Allium cepa and CHO-K1 culture
cells by methyl methanesulfonate (MMS) and doxorubicin
(DXR). MMS is a mono-functional alkylating agent, with
the capacity to generate methylating and ethylating species
that interact with macromolecules, such as DNA. The
MMS concentration used in CHO-K1 cell treatment was
4x1 0
-4 M. DXR is a topoisomerase II inhibitor, which
leads to the formation of simple and double breaks in the
DNA chain and, consequently, to cell-death. It is believed
that the disruption of DNA is also mediated by the genera-
tion of radicals favored by drug-free chemical structures
(Chabner, 1996; Tokudome et al., 2000). The DXR con-
centrationusedforCHO-K1cellculturewas0.75g/mLof
the culture medium.
Investigation of the antimutagenic activity of the R.
manglebarkaqueousextractwascarriedoutbypre-,simul-
taneous and post-treatment protocols, in the Allium cepa
test-system and the CHO-K1 cell micronuclear assay, with
cytokinesis blockage.
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ing ultrapure water, until the roots had reached a length of
approximately 1 cm. Next, the seeds were submitted to on
of the following treatments: pretreatment, in which the
seeds were transferred to a plate containing R. mangle bark
aqueous extract at 1.75 g/L for 24 h, followed by treatment
with mutagenic agent MMS (4 x 10
-4 M) for a further 24 h;
simultaneous treatment, in which the seeds were trans-
ferred to a plate containing R. mangle bark aqueous extract
and mutagenic agent MMS in the proportion of 1:1 (1 ex-
tract:1 MMS, v:v) for 48 h; posttreatment, in which the
seeds were transferred to a plate containing mutagenic
agent MMS for 24 h, followed by treatment with R. mangle
bark aqueous extract for 24 h. All the assays were per-
formedintriplicate.Finally,allthemeristemswerefixedin
Carnoy’s solution (3:1) for 24 h. Cytological analysis was
realized according to the Feulgen method; the roots were
submitted to acid hydrolysis in 1 N HCl at 60 °C for 8 min,
followed by washing in distilled water. Staining was real-
ized with the periodic acid-Schiff reaction for 2 h in the
dark.Rootcellswerethengentlycrushedandsmearedonto
the center of clean slides. 5000 cells per treatment were an-
alyzed.
CHO-K1cells,obtainedfromtheLondrinaStateUni-
versity(UniversidadeEstadualdeLondrina,UEL)inOcto-
ber 2006, were used to perform the antimutagenic assay.
Culture flasks (25 cm
2) were used to seed monolayer cul-
tures in D-MEM/HAM F12 medium, supplemented with
10% bovine fetal serum and 0.1% antibiotic-antimitotic so-
lution. The flasks were maintained in a BOD incubator at
37 °C. Under these conditions, the cell cycle is 12 h. The
different treatments were realized with R. mangle bark
aqueous extract at a concentration of 1.75 g/L, after stabili-
zation of CHO-K1 cell cultures for 48 h. Negative control
was realized with PBS (pH 7.4) and positive controls with
antineoplastic agent DXR (0.75 g/mL of culture medium)
and mutagenic agent MMS (4 x 10
-4 M). The assays were
realized in triplicate. For pretreatment the CHO-K1 cells
were washed twice in PBS (pH 7.4), and cultivated in cul-
ture medium without serum supplementation with 50 Lo f
R. mangle extract for 3 h. Next, the cells were washed with
PBS and submitted to treatment with either of the two posi-
tive controls for 3 h. For simultaneous treatment the CHO-
K1 cells were washed twice in PBS (pH 7.4) and cultivated
in culture medium with 50 Lo fR. mangle extract and
50 L of either of the two positive controls, where they re-
mained for 3 h. In post-treatment the CHO-K1 cells were
washed twice in PBS (pH 7.4) and cultivated in culture me-
dium with either of the two positive controls for 3 h. Next,
thecellswerewashedtwicewithPBSand50LofR.man-
gleextractwasaddedandwheretheyremainedforafurther
period of 3 h. At the end of each treatment, the mediums
were discarded and the cells were washed twice with PBS.
Culture medium and 50 L of cytochalasin B were added.
The CHO-K1 cells remained in cytochalasin for 18 h to in-
duce the formation of binucleated cells. Following the
cytochalasin B treatment, the CHO-K1 were again washed
in PBS and detached with 0.0025% trypsin-EDTA. After
trypsin inactivation with culture medium, one drop of for-
mol was added and the sample was homogenized and cen-
trifuged at 1250 rpm for 5 min. The supernatant was
discarded and 1.5 mL of 1% sodium citrate were added.
The sample was further homogenized and centrifuged at
1250rpmfor5min.Theresultingpelletwasresuspendedin
5 mL of fixer (3 methanol:1 acetic acid, v:v), followed by
centrifugation at 1250 rpm for 5 min. The fixer was re-
moved until cell dilution for slide mounting was achieved,
followed by staining with 5% Giemsa. 1000 cells per treat-
ment were analyzed. Antimutagenic activity in the Allium
cepa test-system and CHO-K1 cell culture were evaluated
by analysis of the percentage reduction of DNA damage in
each of the treatments with the aqueous extract of R. man-
gle bark, calculated according to the formula:
Reduction
n. NM cells in A -n. NM cells in B
n. N
(%) 
M cells in A -n. NM cells in C
100
inwhichn=numberof,A:DNA=damage-inducingagent,
B = associated treatment and C = negative control.
Statistical analysis of the mitotic index was realized
by the Kruskal-Wallis test. Statistical analysis of the num-
ber of micronucleated cells was realized by the Chi-square
test. A p value of < 0.05 was considered significant.
Rhizophora mangle L. is a species that is widely en-
countered in Brazilian mangroves and has expressive im-
portance in the economy of the State of Espirito Santo,
Brazil, since the extract derived from its bark is used in the
fabrication of traditional clay cooking pots. R. mangle bark
isarichredcolor,whichgaveorigintothepopularnameof
mangue-vermelho (roughly translated: red mangrove).
This coloration is derived from the presence of polyphe-
nolic compounds, denominated tannins. These compounds
are characterized by a reductive chemical structure that
yields the capacity for free radical sequestration (Silva et
al., 2003).
Pharmacognostic triage detected the presence of fla-
vonoids (5%), triterpenos (0.5%), anthracene heterosideos
(traces) and hydrolyzable and condensed tannins (49.8%)
The tannin dosage of the aqueous extract of R. mangle bark
was49.8%tannins(hydrolyzableandcondensed),datathat
is in agreement with that obtained by Silva et al (Sanchez,
1998).
Evaluation of toxicity in Allium cepa revealed a de-
creasing dose-dependent relation between root growth and
extract concentration, indicating that the toxicity of the ex-
tracts is proportional to an increase in the concentration of
the same (Figure 1). This parameter indicated that extracts
at concentrations of 1.75 g/L, 3.5 g/L and 7.0 g/L were ade-
quateforuseinbiologicalexperiments,sincetherootsorig-
inating from seeds germinated at these concentrations
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cytotoxicityanalysis,themitoticindexofA.ceparootswas
evaluated (Table 1). Observation verified that the number
of cells presenting cell division was greater for the treat-
ment with the lowest concentration, since at this concentra-
tion, greater root development occurred resulting from
mitoticcelldivision.Followinganalysisofthetwoparame-
ters evaluated, toxicity and cytotoxicity, the concentration
of 1.75 g/L was determined as the fraction that should be
used in the development of the mutagenicity and anti-
mutagenicity studies.
Evaluation of possible antimutagenic activity of the
R. mangle bark aqueous extract was realized by in vivo and
in vitro assays, using the A. cepa test-system and CHO-K1
cell culture, respectively. In both the A. cepa test-system
and CHO-K1 cell culture, R. mangle extract presented
antimutagenic activity and absence of mutagenicity.
The antimutagenic effect was evaluated by pre-, si-
multaneous and post-treatment protocols to determine
whether R. mangle extract acted as a demutagenic agent,
i.e., that it inactivated mutagenic agents, chemically or en-
zymatically, prior to their interaction with genetic material;
and/orasabio-antimutagenicagent,assistinginthecapture
of free radicals and potentiating DNA repair mechanisms
(Kada et al., 1982).
The A. cepa test-system indicated antimutagenic ac-
tivity in pre and post-treatments with R. mangle extract at a
concentration of 1.75 g/L, in relation to damage induced by
the MMS mutagenic agent. The meristematic cells of A.
cepa submitted to pretreatment with R. mangle extract pre-
sented a 95.1% reduction in micronuclear cell frequency
and chromosome breaks induced by MMS. Under post-
treatment conditions, there was an 85.0% reduction in
DNA damage. On the contrary, no reduction in the rate of
mutagenicity was observed during simultaneous treatment
(Table 2).
TheMNtestinCHO-K1cellsdetectedantimutagenic
activity for R. mangle extract (1.75 g/L) in all the treat-
ments evaluated against the damage induced by the muta-
genic agent MMS and the antineoplastic agent DXR. The
reduction in the damage induced by MMS was lower in the
pre and posttreatment protocols when compared to DXR;
however, in the simultaneous treatment protocol, no differ-
ence in the rate of reduction was observed between the two
agents (Table 2).
The hypothesis regarding the bio-antimutagenic and
demutagenicactivityoftheR.mangleextractintheA.cepa
test-system and CHO-K1 cell culture assays was supported
by the presence of phytoconstituents in the extract that pre-
sented protective activity. Since the pharmacognostic tri-
age and the dosage of the R. mangle bark aqueous extract
determined that its chemical constitution presented a high
content of tannins, it can be inferred that these polyphenols
are the phytoconstituents that promoted the protective ef-
fect on the DNA molecules. The high antioxidant potential,
which is characteristic of tannins, facilitates their acting
through antimutagenic pathways, thereby capturing free
radicals and contributing to the maintenance of cell stabil-
ity (Picada et al., 2003).
TheresultswithR.mangleininvivoandinvitrotreat-
ments revealed pronounced desmutagenic and bio-anti-
mutagenic activity. The mechanism of demutagenic
activityofR.manglebarkaqueousextractisalsosuggested
by the interaction of tannin with metallic ions (Santos and
Mello, 2003), thereby impeding that these ions participate
in the reaction that transforms hydrogen peroxide into wa-
ter, consequently inhibiting the formation of free radicals
OH
- and hindering an attack on DNA molecules.
A possible mechanism of the bio-mutagenic action of
the extract R. mangle is its actuation in the DNA repair sys-
tem, that was implicated because the inhibition of the DNA
topoisomerase II by the antineoplasic agent (Chabner,
1996; Tokudome et al., 2000). In this way, the fixation of
the mutations produced by the reactive oxygen species be-
causetheinefficiencyofthetopoisomeraseIIactivityisde-
creased.
As the structure of chemical mutagens which favor
the generation of free radicals result in increased oxidative
stress, the primary desmutagenic action is to help intercept
these radicals or even increase the production of antioxi-
dant proteins to facilitate bio-antimutagenic action of tan-
nins, thus reducing the amount of damage to be repaired.
During the simultaneous treatment, antimutagenic
activity was not observed in the A. cepa test-system; how-
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Figure 1 - Growth of the roots of A. cepa seeds submitted to germination
in different dilutions of R. mangle bark aqueous extract.
Table 1 - Mean values of the frequency of the mitotic indices of the
meristems of A. cepa submitted to treatment with different concentrations
of R. mangle bark aqueous extract.
Samples Mitotic index (x) Root length (mm)
Negative control 0.029 12.50
Extract 28.0 g/L 0.000 2.0
Extract 14.0 g/L 0.003 7.5
Extract 7.00 g/L 0.023 9.0
Extract 3.50 g/L 0.036 10.0
Extract 1.75 g/L 0.041* 17.0
*Statistically significant difference by the Kruskal-Wallis test for the
mean root length, in relation to extract concentration 28.0 g/L.ever in the CHO-K1 cell culture test, the antimutagenic ac-
tivity of the extract was observed for both DNA damage
inductors (MMS and DXR). According to Rodrigues and
Monteleone-Neto (1991), in vitro studies are the more ad-
vantageous by facilitating high-precision evaluation of the
action of compounds at the cell level, because the experi-
mental conditions are controlled. According to Calixto
(2001), the effects observed in in vitro tests are frequently
notininvivo,duetodifficultiesinreproducibilityinthelat-
ter.
Analysis of the present results suggests that aqueous
extract of Rhizophora mangle bark used in the fabrication
of domestic utensils by the pot-makers association of the
city of Vitória, ES, Brazil, does not present mutagenic ac-
tivity, rather it acted as a demutagenic agent in the Allium
cepa test-system and CHO-K1 cells and as a bio-anti-
mutagenic agent in CHO-K1 cell cultures.
Acknowledgments
This research was financially supported by the Fundo
de Apoio à Ciência e Tecnologia of the municipality of
Vitória, ES, Brazil.
References
CalixtoJB(2001)PlantasMedicinaissobaÓticadaQuímicaMe-
dicinal Moderna. 1 edição. Argos, Santa Catarina, 500 pp.
Chabner BA (1996) Agentes antineoplásicos. In: Gilman AG and
Goodman LS (eds) As Bases Farmacológicas da Terapêu-
tica. McGraw Hill, New York, pp 909-949.
EvseevaTIandKhramovaES(2002)Actionoflowconcentration
of
232Th on tradescantia (clone 02) and meristematic root itp
cells of Allium cepa. In: Proceedings of the fifth Interna-
tional Conference on High Levels of Natural Radiation and
Radon Areas, Munich, pp 489-491.
Farmacopéia Brasileira (2001) 4th edition. Atheneu, São Paulo,
294 pp.
Fiskejö G (1985) The Allium test as a standard in environmental
monitoring. Hereditas 102:99-112.
Houghton PJ and Raman A (1998) Laboratory Handbook for the
Fractionation of Natural Extracts. 2 edition. Springer, Lon-
don, 212 pp.
Kada T, Inoue T and Namiki N (1982) Environmental desmu-
tagens and antimutagens. In: Klekowski EJ (ed) Environ-
mental Mutagenesis and Plant Biology. Praeger, New York,
pp 137-151.
Matsumoto ST, Fonseca I, Marin-Morales MA, Mantovani MS,
Malagutti MI and Dias AL (2006) Genotoxicity and muta-
genicity of water contaminated with tannery effluents, as
180 Antimutagenicity of a Rhizophora mangle extract
Table 2 - Frequency of cells with micronuclei and percentage reduction of chromosome damage in cells of A. cepa and CHO-K1 submitted to treatment
with R. mangle bark aqueous extract
Treatments Frequency of cells with MN (1000 cells/experiment)
Experiments X  SD % (chromosome damage)
I II III
Allium cepa Negative control 0.0 0.0 1.0 0.33  0.00 -
MMS 7.0 8.0 5.0 6.67  1.53* -
Extract 1.75 g/L 1.0 0.0 0.0 0.33  0.00 -
Pre MMS 0.0 0.0 1.0 0.33  0.58** 95.1
Simultaneous MMS 12 19 17 16.0  3.61*** 0.00
Post MMS 1.0 1.0 1.0 1.00  0.00** 85.0
CHO-K1 Negative control 1.0 1.0 1.0 1.00  0.00 -
MMS 27 28 47 34.0  11.3* -
DXR 42 25 36 34.3  8.62* -
Extract 1.75 g/L 0.0 1.0 2.0 1.00  0.82 -
Pre MMS 25 6.0 6.0 12.3  11.0** 65.8
Pre DXR 5.0 0.0 4.0 3.00  2.65*** 94.8
Simultaneous MMS 8.0 12 7.0 9.00  2.16** 76.0
Simultaneous DXR 10 13 4.0 9.00  3.37*** 76.0
Post MMS 19 21 25 21.6  2.49** 38.1
Post DXR 16 16 15 15.6  0.47*** 56.1
MMS, methyl methanesulfonate; DXR, doxorubicin; X, mean; SD, Standard deviation.
*Statistical difference from negative control (p  0.05).
**Statistical difference from MMS (p  0.05).
***Statistical difference from DXR (p  0.05).evaluated by the micronucleus test and comet assay using
the fish Oreochromis niloticus and chromosome aberrations
in onion root-tips. Genet Mol Biol 29:148-158.
Matsumoto ST and Marin-Morales MA (2004) Mutagenic poten-
tialevaluationofthewaterofariverthatreceivestanneryef-
fluent using the Allium cepa test system. Cytologia 69:399-
408.
MelloMLSandVidalBC(1978)AreaçãodeFeulgen.CiêncCult
30:665-676.
Picada JN, Kern AL, Ramos ALP and Saffi J (2003) O estresse
oxidativoeasdefesasantioxidantes.In:SilvaJ,ErdtmannB
and Henriques JAP (eds) Genética Toxicológica. Editora
Alcance, Porto Alegre, pp 349-468.
Rodrigues MALR and Monteleone-Neto R (1991) Teste de
micronúcleo em medula óssea. In: Rabello-Gay MN, Rodrí-
guez MALR e Monteleone-Neto R (eds) Mutagênese, Car-
cinogênese e Teratogênese: Métodos e Critérios de Avalia-
ção. Sociedade Brasileira de Genética, Ribeirão Preto,
pp 83-90.
Roig JT (1974) Plantas Medicinales, Aromáticas y Venenosas de
Cuba.EditorialRevoluciónyprogresso,LaHabana,949pp.
Sanchez LM (1998) Chemical and toxicological characterization
of Rhizophora mangle L. wound-healing formulation. Rev
Salud Anim 20:69-72.
Santos SC and Mello JCP (2003) Farmacognosia: Da planta ao
Medicamento. 5th edition. Editora da UFRGS e Editora da
UFSC, Porto Alegre e Florianópolis, 1102 pp.
Silva J, Erdtmann B and Henriques JAP (2003) Genética Toxico-
lógica. 1st edition. Editora Alcance, Porto Alegre, 424 pp.
Tokudome T, Mizushige K, Noma T, Manabe K, Murakami K,
Tsuji T, Nozakis S and Tomohiro A (2000) Prevention of
doxorubicin (adriamycin)-induced cardiomyopathy by si-
multaneous administration of angiotensin-converting enzy-
me inhibitor assessed by acoustic densitometry. J Cardio-
vasc Pharmacol 36:361-368.
Associate Editor: Catarina S. Takahashi
License information: This is an open-access article distributed under the terms of the
Creative Commons Attribution License, which permits unrestricted use, distribution, and
reproduction in any medium, provided the original work is properly cited.
Malini et al. 181